Pfizer PFE is set to report earnings tomorrow before the bell, and Wall Street will be looking to see how expiring drugs are going to affect the company's earnings going forward, as well as any more clarity on the breakup of the company.
At last check, shares of Pfizer were up 7 cents to $21.04, a gain of 0.33% on 24 million shares today. The company has a 3.8% dividend yield, and trades at 9.8 times 2012 earnings.
Wall Street is looking for earnings of 59 cents per share on revenues of $16.65 billion, down 0.5% from last year, when it reported earnings of 60 cents per share on revenues of $16.74 billion.
Guidance for next quarter is expected to come in at 59 cents per share on $17.07 billion in revenues.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in